Table 3 Cox regression models with total mortality as outcome for patients for patients aged ≥45 years with diagnoses of AF and diabetes mellitus ( n = 2,413) attending the 75 PHCCs between January 1st2001 and December 31st2007, stratified by age: 45–79 years (n = 1,704) and 80–104 years (n = 709)
Patients aged <80 years | Patients aged ≥80 years | All patients | |
|---|---|---|---|
Full model | Full model | Full model | |
HR (95% CI) | HR (95% CI) | HR (95% CI) | |
Antithrombotic drugs | |||
Antiplatelets vs. no treatment | 0.86 (0.43-1.72) | 0.47 (0.26-0.87) | 0.70 (0.45-1.09) |
Anticoagulants vs. no treatment | 0.40 (0.17-0.91) | 0.49 (0.24-1.00) | 0.45 (0.26-0.77) |
Anticoagulants vs. antiplatelets | 0.44 (0.25-0.78) | 1.02 (0.60-1.73) | 0.62 (0.42-0.92) |
Digitalis | 0.81 (0.54-1.23) | 0.90 (0.60-1.35) | 0.83 (0.62-1.11) |
Loop diuretics | 2.42 (1.36-4.33) | 1.02 (0.60-1.73) | 1.55 (1.06-2.28) |
Thiazides | 0.98 (0.59-1.63) | 0.89 (0.55-1.44) | 0.93 (0.66-1.32) |
Aldosterone antagonists | 1.20 (0.76-1.88) | 1.22 (0.79-1.88) | 1.29 (0.94-1.77) |
Beta blockers | 0.62 (0.40-0.97) | 0.73 (0.49-1.10) | 0.67 (0.49-0.90) |
RAS-blocking agents | 1.08 (0.65-1.78) | 1.23 (0.79-1.93) | 1.16 (0.83-1.62) |
Calcium receptor-blocking agents | 1.06 (0.69-1.63) | 1.20 (0.77-1.87) | 1.10 (0.81-1.49) |
Statins | 0.45 (0.29-0.71) | 0.77 (0.47-1.26) | 0.56 (0.40-0.78) |